-
FDA taps PatientsLikeMe to test the waters of social media adverse event reporting
mobihealthnews | PatientsLikeMe has announced a research partnership with the FDA: The agency will assess the platform's feasibility as a way to generate adverse event reports, which the FDA uses to regulate drugs after their release into the market.
Jun 16, 2015
-
Matthew Trunnell Joins Fred Hutchinson Cancer Research Center
Xconomy | Trunnell leaves the Broad to serve as the chief information officer as the biomedical institution moves into an era of deep genomic sequencing.
Jun 16, 2015
-
Outpouring of Commentary on CRISPR Germline Editing
Bio-IT World News Brief | A supplementary document to a recent Nature Biotechnology article on the use of CRISPR-Cas9 genome editing in the human germline offers complete Q&A's with over 20 experts in the field, taking on pressing questions about how and whether this technology can be regulated.
Jun 10, 2015
-
ClinGen and Lessons for the Precision Medicine Initiative
Bio-IT World | Heidi Rehm has been involved in ClinGen since its inception and recently published a report on the project in the New England Journal of Medicine. Rehm’s experience with ClinGen will make hers an important voice as the infrastructure needs for a Precision Medicine Initiative are better defined.
Jun 10, 2015
-
BGI's Industrial Scale Sequencer Challenges Illumina's HiSeq Line
Bio-IT World | BGI, the Shenzhen-based global genomics corporation, has revealed its first DNA sequencing instrument for worldwide markets, Revolocity: an ultra-high-throughput, fully automated system based on technology developed by BGI's subsidiary Complete Genomics.
Jun 8, 2015
-
Kickstarter Launched for Social Reader
Bio-IT World | David Mittelman and his colleagues at N of Everyone today launch a Kickstarter campaign to fund Reader, a mobile and social reading platform to promote conversation and collaboration within science.
Jun 8, 2015
-
The Human Virome's Permanent Mark
Bio-IT World | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.
Jun 5, 2015
-
Celgene Bluebird Streamline CAR-T Partnership To Fight Myeloma
Xconomy | The immuno-oncology field is moving fast these days, but the tough-to-treat blood cancer multiple myeloma has not been one of its early targets.
Jun 4, 2015
-
Business The billion-dollar biotech
Nature News & Comment | Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling start-up became one of the most highly valued private drug firms ever.
Jun 4, 2015
-
Genomics England Names Four Finalist Companies to Begin Interpretation
Bio-IT World News Brief | Genomics England today announced four finalist companies and one alternate that will begin working on the interpretation of the genomes of the first 8,000 patients participating in the 100,000 Genomes Project. Congenica and Omicia will work in rare diseases, Nanthealth in cancer, and Wuxi Nextcode in both rare disease and cancer for this stage of the project. Lockheed Martin in partnership with Cypher Genomics is the alternate.
Jun 3, 2015
-
BaseHealth Opens Its Genomic Health Engine to Outside Developers
Bio-IT World | BaseHealth, an Illumina-associated company using genomic data to provide patients with personalized health recommendations, is shifting to a more behind-the-scenes model, releasing an open API to integrate its own analysis engine into third-party apps and health platforms.
Jun 2, 2015
-
Invitae Launches Direct-to-Consumer Pricing
Bio-IT World | Invitae Corporation today announced a patient pay price for its full menu of genetic tests. For $475 per indication, patients can pay for their own genetic tests if insurance coverage is not available. The price covers all of Invitae’s offerings in cancer, cardiology, neurology, pediatric genetics, hematology and other rare conditions
Jun 1, 2015
-
May News and Product Briefs
Bio-IT World | News and product briefs from around the industry, including a suite of new proteomics and lipidomics solutions from SCIEX, and new efforts at the Broad Institute to understand the mechanisms of cancer drug resistance.
Jun 1, 2015
-
Google cloud strategy focuses on analyzing big data
Computerworld | Google may not have caught up to Amazon in the cloud market, but that's OK, according to a Google executive. The company is heading in a slightly different direction with cloud computing that involves helping customers analyze their data.
Jun 1, 2015
-
Definiens Launches Biomarker Datafication Services
Bio-IT World News Brief | Definiens today launched a new suite of Biomarker Datafication Services for oncology clinical development programs. The package provides image analysis screening of tissue samples for exploratory screening, pharmacokinetics/pharmacodynamics, and companion diagnostic development.
May 29, 2015
-
PacBio Aims for Haplotyped Whole Genome Assemblies in Partnership with RainDance
Bio-IT World | Months after 10X Genomics came to market with a platform for reassembling 100-kilobase DNA fragments with an Illumina sequencer, Pacific Biosciences and RainDance Technologies have teamed up on their own barcoded long read solution that they say could outperform 10X on virtually every count.
May 29, 2015
-
Strand LS Expands Cancer Profiling Service
Bio-IT World News Brief | Strand Life Sciences announced an expanded StrandAdvantage pan-cancer genomic profiling service. The new version of StrandAdvantage will include a panel that examines 152 genes and pathways known to be impacted by existing targeted solid tumor therapies plus additional chemotherapeutic toxicity and resistance data.
May 28, 2015
-
Juno Therapeutics Partners with Editas Medicine on CRISPR-Engineered Cancer Immunotherapies
Bio-IT World | Biotech funding must be hot indeed when an 18-month-old immunotherapy company can pledge hundreds of millions to an 18-month-old genome editing company, but there's plenty of promise combining CAR T therapy with CRISPR technology — as rivals Novartis and Intellia Therapeutics made clear when they forged their own partnership this January.
May 27, 2015
-
QIAGEN Launches NGS Clinical Insights Platform
Bio-IT World News Brief | Yesterday afternoon QIAGEN announced the commercial launch of QIAGEN Clinical Insight (QCI), a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS). The first two supported applications for the bioinformatics platform are in oncology, for somatic and hereditary cancer testing.
May 27, 2015
-
New CLARITY Challenge Open to Entries, to Tackle Undiagnosed Diseases
Clinical Informatics News | Boston Children’s Hospital is launching CLARITY Undiagnosed, a $25,000 competition to identify molecular diagnoses for five families with as-yet undiagnosed conditions. The Challenge kicks off in conjunction with a documentary film tracing the journeys of the patients and—possibly—the teams. Teams have until June 11 to register
May 21, 2015